 | Up a level |
C
Carr-Wilkinson, Jane (2005) Aberrations of the p53/p14ARF/MDM2 pathway in neuroblastoma cell lines derived from progressive and/or relapsed tumours. In: American Association for Cancer Research, 2005, California, USA. (Submitted)
G
Gnanapragasam, VJ, Darby, Steven, Khan, M M, Lock, WG, Robson, CN and Leung, HY (2005) Evidence that prostate gonadotropin-releasing hormone receptors mediate an anti-tumourigenic response to analogue therapy in hormone refractory prostate cancer. The Journal of Pathology, 206 (2). pp. 205-213. ISSN 0022-3417
H
Hardcastle, IR, Ahmed, Shafiq, Atkins, H, Calvert, AH, Curtin, NJ, Farnie, G, Golding, BT, Griffin, RJ, Guyenne, S, Hutton, C, Kallblad, P, Kemp, SJ, Kitching, MS, Newell, DR, Norbedo, S, Northen, JS, Reid, RJ, Saravanan, K, Willems, H and Lunec, J (2005) Isoindolinone-based inhibitors of the MDM2-p53 protein-protein interaction. Bioorganic & Medicinal Chemistry Letters, 15 (5). pp. 1515-1520.
V
Veuger, Stephany and Durkacz, B W (2005) PARP-1 function is essential for resistance to ionising radiation mediated by NFkB activation. Proceedings of the American Association for Cancer research, 2002 (181).
Visram, S, Crosland, Ann, Unsworth, John and Long, S (2005) Barriers and facilitators to engaging women from black and ethnic minority communities in cardiac rehabilitation(Abstract no. 127). Family Practice, 22 (supp.1). pp. 85-86. ISSN 0263-2136
W
Wilkes, Scott, Evans, A, Henderson, M and Gibson, J (2005) A Pragmatic observational study of the success of Bupropion for smoking cessation in one general practice. Post Graduate Medical Journal, 81 (961). pp. 719-722. ISSN 1469-0756